skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 104,260  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: Journal Title: Blood remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study
Material Type:
Article
Add to My Research

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study

Blood, 2008-09, Vol.112 (6), p.2242-2247 [Peer Reviewed Journal]

2008 American Society of Hematology ;2008 INIST-CNRS ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2008-05-160143 ;PMID: 18621928

Full text available

2
Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor
Material Type:
Article
Add to My Research

Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor

Blood, 2017-01, Vol.129 (2), p.257-260 [Peer Reviewed Journal]

2017 American Society of Hematology ;2017 by The American Society of Hematology 2017 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2016-10-745133 ;PMID: 27908881

Full text available

3
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study
Material Type:
Article
Add to My Research

Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study

Blood, 2019-02, Vol.133 (6), p.540-549 [Peer Reviewed Journal]

2019 American Society of Hematology ;2019 by The American Society of Hematology. ;2019 by The American Society of Hematology 2019 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2018-09-876805 ;PMID: 30510079

Full text available

4
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study
Material Type:
Article
Add to My Research

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study

Blood, 2020-10, Vol.136 (18), p.2038-2050 [Peer Reviewed Journal]

2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 0006-4971 ;ISSN: 1528-0020 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020006844 ;PMID: 32731259

Full text available

5
Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism
Material Type:
Article
Add to My Research

Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism

Blood, 2019-11, Vol.134 (19), p.1645-1657 [Peer Reviewed Journal]

2019 American Society of Hematology ;Distributed under a Creative Commons Attribution 4.0 International License ;2019 ;ISSN: 0006-4971 ;ISSN: 1528-0020 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2019000435 ;PMID: 31420334

Full text available

6
Venous thromboembolism in cancer patients: a population-based cohort study
Material Type:
Article
Add to My Research

Venous thromboembolism in cancer patients: a population-based cohort study

Blood, 2021-04, Vol.137 (14), p.1959-1969 [Peer Reviewed Journal]

2021 American Society of Hematology ;2021 by The American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020007338 ;PMID: 33171494

Full text available

7
Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster AML-study group
Material Type:
Article
Add to My Research

Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster AML-study group

Blood, 2013-10, Vol.122 (15), p.2704-2713 [Peer Reviewed Journal]

2013 American Society of Hematology ;2013 by The American Society of Hematology 2013 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2013-02-485524 ;PMID: 23974201

Full text available

8
A study of ruxolitinib response–based stratified treatment for pediatric hemophagocytic lymphohistiocytosis
Material Type:
Article
Add to My Research

A study of ruxolitinib response–based stratified treatment for pediatric hemophagocytic lymphohistiocytosis

Blood, 2022-06, Vol.139 (24), p.3493-3504 [Peer Reviewed Journal]

2022 American Society of Hematology ;Copyright © 2022 American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2021014860 ;PMID: 35344583

Full text available

9
Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL
Material Type:
Article
Add to My Research

Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL

Blood, 2016-06, Vol.127 (24), p.2980-2990 [Peer Reviewed Journal]

2016 American Society of Hematology ;2016 by The American Society of Hematology. ;2016 by The American Society of Hematology 2016 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2015-12-686725 ;PMID: 27118452

Full text available

10
Phase 2b study of 2 dosing regimens of quizartinib monotherapy in FLT3-ITD–mutated, relapsed or refractory AML
Material Type:
Article
Add to My Research

Phase 2b study of 2 dosing regimens of quizartinib monotherapy in FLT3-ITD–mutated, relapsed or refractory AML

Blood, 2018-08, Vol.132 (6), p.598-607 [Peer Reviewed Journal]

2018 American Society of Hematology ;2018 by The American Society of Hematology. ;2018 by The American Society of Hematology 2018 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2018-01-821629 ;PMID: 29875101

Full text available

11
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
Material Type:
Article
Add to My Research

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Blood, 2015-07, Vol.126 (3), p.291-299 [Peer Reviewed Journal]

2015 American Society of Hematology ;2015 by The American Society of Hematology. ;2015 by The American Society of Hematology 2015 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2015-01-621664 ;PMID: 25987659

Full text available

12
Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study
Material Type:
Article
Add to My Research

Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study

Blood, 2020-07, Vol.136 (1), p.144-147 [Peer Reviewed Journal]

2020 American Society of Hematology ;Copyright © 2020 American Society of Hematology. 2020 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020006941 ;PMID: 32462179

Full text available

13
A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)
Material Type:
Article
Add to My Research

A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)

Blood, 2021-03, Vol.137 (12), p.1582-1590 [Peer Reviewed Journal]

2021 American Society of Hematology ;2021 by The American Society of Hematology. ;2021 by The American Society of Hematology 2021 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020007848 ;PMID: 33067614

Full text available

14
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease
Material Type:
Article
Add to My Research

A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease

Blood, 2019-04, Vol.133 (17), p.1865-1875 [Peer Reviewed Journal]

2019 American Society of Hematology ;2019 by The American Society of Hematology. ;2019 by The American Society of Hematology 2019 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2018-08-868893 ;PMID: 30655275

Full text available

15
Chronic graft-versus-host disease: biological insights from preclinical and clinical studies
Material Type:
Article
Add to My Research

Chronic graft-versus-host disease: biological insights from preclinical and clinical studies

Blood, 2017-01, Vol.129 (1), p.13-21 [Peer Reviewed Journal]

2017 American Society of Hematology ;2017 by The American Society of Hematology. ;2017 by The American Society of Hematology 2017 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2016-06-686618 ;PMID: 27821504

Full text available

16
Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies
Material Type:
Article
Add to My Research

Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies

Blood, 2021-04, Vol.137 (16), p.2231-2242 [Peer Reviewed Journal]

2021 American Society of Hematology ;2021 by The American Society of Hematology. ;2021 by The American Society of Hematology 2021 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020009217 ;PMID: 33512413

Full text available

17
Common variable immune deficiency: case studies
Material Type:
Article
Add to My Research

Common variable immune deficiency: case studies

Blood, 2019-11, Vol.134 (21), p.1787-1795 [Peer Reviewed Journal]

2019 American Society of Hematology ;2019 by The American Society of Hematology. ;2019 by The American Society of Hematology 2019 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2019002062 ;PMID: 31751486

Full text available

18
Role of Hypercoagulable Studies in Cryptogenic Stroke: A Retrospective Study
Material Type:
Article
Add to My Research

Role of Hypercoagulable Studies in Cryptogenic Stroke: A Retrospective Study

Blood, 2020-11, Vol.136 (Supplement 1), p.33-33 [Peer Reviewed Journal]

2020 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2020-136723

Full text available

19
Do MYC Alterations Matter in HIV-Associated Large B Cell Lymphomas? the “Euromyc” Study (a European retrospective study)
Material Type:
Article
Add to My Research

Do MYC Alterations Matter in HIV-Associated Large B Cell Lymphomas? the “Euromyc” Study (a European retrospective study)

Blood, 2021-11, Vol.138 (Supplement 1), p.2506-2506 [Peer Reviewed Journal]

2021 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2021-151149

Full text available

20
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
Material Type:
Article
Add to My Research

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

Blood, 2017-10, Vol.130 (16), p.1800-1808 [Peer Reviewed Journal]

2017 American Society of Hematology ;2017 by The American Society of Hematology. ;2017 by The American Society of Hematology 2017 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2017-03-769620 ;PMID: 28774879

Full text available

Results 1 - 20 of 104,260  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (104,246)

Refine My Results

Creation Date 

From To
  1. Before 1964  (776)
  2. 1964 To 1978  (1,420)
  3. 1979 To 1993  (6,895)
  4. 1994 To 2009  (33,242)
  5. After 2009  (61,922)
  6. More options open sub menu

Language 

  1. English  (104,259)
  2. Japanese  (6,593)
  3. Russian  (15)
  4. Norwegian  (3)
  5. Portuguese  (1)
  6. French  (1)
  7. Swedish  (1)
  8. More options open sub menu

Searching Remote Databases, Please Wait